These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 29557714)

  • 1. Piroxicam cocrystals with phenolic coformers: preparation, characterization, and dissolution properties.
    Emami S; Adibkia K; Barzegar-Jalali M; Siahi-Shadbad M
    Pharm Dev Technol; 2019 Feb; 24(2):199-210. PubMed ID: 29557714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solid state manipulation of lornoxicam for cocrystals--physicochemical characterization.
    Nijhawan M; Santhosh A; Babu PR; Subrahmanyam CV
    Drug Dev Ind Pharm; 2014 Sep; 40(9):1163-72. PubMed ID: 23829186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resveratrol cocrystals with enhanced solubility and tabletability.
    Zhou Z; Li W; Sun WJ; Lu T; Tong HHY; Sun CC; Zheng Y
    Int J Pharm; 2016 Jul; 509(1-2):391-399. PubMed ID: 27282539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmaceutical Cocrystal of Piroxicam: Design, Formulation and Evaluation.
    Panzade P; Shendarkar G; Shaikh S; Balmukund Rathi P
    Adv Pharm Bull; 2017 Sep; 7(3):399-408. PubMed ID: 29071222
    [No Abstract]   [Full Text] [Related]  

  • 5. Formation of itraconazole-succinic acid cocrystals by gas antisolvent cocrystallization.
    Ober CA; Gupta RB
    AAPS PharmSciTech; 2012 Dec; 13(4):1396-406. PubMed ID: 23054991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insight into the solubility and dissolution behavior of piroxicam anhydrate and monohydrate forms.
    Paaver U; Lust A; Mirza S; Rantanen J; Veski P; Heinämäki J; Kogermann K
    Int J Pharm; 2012 Jul; 431(1-2):111-9. PubMed ID: 22554403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation, structural analysis, and properties of tenoxicam cocrystals.
    Patel JR; Carlton RA; Needham TE; Chichester CO; Vogt FG
    Int J Pharm; 2012 Oct; 436(1-2):685-706. PubMed ID: 22841852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation strategy and evaluation of nanocrystal piroxicam orally disintegrating tablets manufacturing by freeze-drying.
    Lai F; Pini E; Corrias F; Perricci J; Manconi M; Fadda AM; Sinico C
    Int J Pharm; 2014 Jun; 467(1-2):27-33. PubMed ID: 24680963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Aceclofenac Cocrystals with l-Cystine: Virtual Coformer Screening, Mechanochemical Synthesis, and Physicochemical Investigations.
    Kumar S; Gupta A; Prasad R; Singh S
    Curr Drug Deliv; 2021; 18(1):88-100. PubMed ID: 32807053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanocrystals as tool to improve piroxicam dissolution rate in novel orally disintegrating tablets.
    Lai F; Pini E; Angioni G; Manca ML; Perricci J; Sinico C; Fadda AM
    Eur J Pharm Biopharm; 2011 Nov; 79(3):552-8. PubMed ID: 21820052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cocrystals of diacerein: Towards the development of improved biopharmaceutical parameters.
    Tomar S; Chakraborti S; Jindal A; Grewal MK; Chadha R
    Int J Pharm; 2020 Jan; 574():118942. PubMed ID: 31830577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural characterization and dissolution profile of mycophenolic acid cocrystals.
    Zeng QZ; Ouyang J; Zhang S; Zhang L
    Eur J Pharm Sci; 2017 May; 102():140-146. PubMed ID: 28254392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel strategy for pharmaceutical cocrystal generation without knowledge of stoichiometric ratio: myricetin cocrystals and a ternary phase diagram.
    Hong C; Xie Y; Yao Y; Li G; Yuan X; Shen H
    Pharm Res; 2015 Jan; 32(1):47-60. PubMed ID: 24939640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and Characterization of Dapsone Cocrystal Prepared by Scalable Production Methods.
    do Amaral LH; do Carmo FA; Amaro MI; de Sousa VP; da Silva LCRP; de Almeida GS; Rodrigues CR; Healy AM; Cabral LM
    AAPS PharmSciTech; 2018 Aug; 19(6):2687-2699. PubMed ID: 29968042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving the solubility of dexlansoprazole by cocrystallization with isonicotinamide.
    Li J; Wang L; Ye YQ; Fu X; Ren Q; Zhang H; Deng Z
    Eur J Pharm Sci; 2016 Mar; 85():47-52. PubMed ID: 26836368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chrysin cocrystals: Characterization and evaluation.
    Chadha R; Bhalla Y; Nandan A; Chadha K; Karan M
    J Pharm Biomed Anal; 2017 Feb; 134():361-371. PubMed ID: 27894779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards improved solubility of poorly water-soluble drugs: cryogenic co-grinding of piroxicam with carrier polymers.
    Penkina A; Semjonov K; Hakola M; Vuorinen S; Repo T; Yliruusi J; Aruväli J; Kogermann K; Veski P; Heinämäki J
    Drug Dev Ind Pharm; 2016; 42(3):378-88. PubMed ID: 26065533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. X-ray powder diffractometry in combination with principal component analysis--a tool for monitoring solid state changes.
    Kogermann K; Veski P; Rantanen J; Naelapää K
    Eur J Pharm Sci; 2011 Jul; 43(4):278-89. PubMed ID: 21575718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dry Mechanochemical Synthesis of Caffeine/Oxalic Acid Cocrystals and Their Evaluation by Powder X-Ray Diffraction and Chemometrics.
    Otsuka Y; Ito A; Takeuchi M; Tanaka H
    J Pharm Sci; 2017 Dec; 106(12):3458-3464. PubMed ID: 28797789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved pharmaceutical properties of ritonavir through co-crystallization approach with liquid-assisted grinding method.
    Chaudhari KR; Savjani JK; Savjani KT; Shah H
    Drug Dev Ind Pharm; 2021 Oct; 47(10):1633-1642. PubMed ID: 35156497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.